Lothar Leimer
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Platelet Disorders and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Biochemistry top 5%
- Blood transfusion and management
Papers in ⓘ
-
- Chronic Myeloid Leukemia Treatments 5
- Hematopoietic Stem Cell Transplantation 3
- Platelet Disorders and Treatments 2
- Acute Myeloid Leukemia Research 2
- Genetics 5
- Chronic Lymphocytic Leukemia Research 4
- Blood disorders and treatments 2
- Co-authors
- Markus Schaich (5 shared papers)Dieter Hoelzer (8 shared papers)Knut Wendelin (4 shared papers)Nicola Gökbuget (4 shared papers)Albrecht Reichle (4 shared papers)Reingard Stuhlmann (3 shared papers)Hubert Serve (4 shared papers)H. Diedrich (4 shared papers)
In The Last Decade
Lothar Leimer
14 papers receiving 812 citations
Peers
Comparison fields: 5 of 64
- Hematology 490
- Biochemistry 144
- Public Health, Environmental and Occupational Health 430
- Genetics 132
- Oncology 264
Countries citing papers authored by Lothar Leimer
This map shows the geographic impact of Lothar Leimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Leimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Leimer more than expected).
Fields of papers citing papers by Lothar Leimer
This network shows the impact of papers produced by Lothar Leimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Leimer. The network helps show where Lothar Leimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Lothar Leimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 321 | |
| 2 | 2012 | 210 | |
| 3 | Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. | 2003 | 77 |
| 4 | 2010 | 44 | |
| 5 | 2010 | 43 | |
| 6 | 2003 | 39 | |
| 7 | 2003 | 27 | |
| 8 | 2008 | 20 | |
| 9 | 1999 | 16 | |
| 10 | 2008 | 13 | |
| 11 | 2006 | 7 | |
| 12 | 2005 | 6 | |
| 13 | 2012 | 4 | |
| 14 | 2008 | 1 |
About Lothar Leimer
Lothar Leimer is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Molecular Medicine and Biochemistry, having authored 14 papers that have together received 828 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Blood disorders and treatments (2 papers), Platelet Disorders and Treatments (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Hematology (490 citations), Biochemistry (144 citations), Public Health, Environmental and Occupational Health (430 citations), Genetics (132 citations) and Oncology (264 citations). Lothar Leimer has collaborated with scholars based in Germany, Italy and Spain. Frequent co-authors include Markus Schaich, Dieter Hoelzer, Knut Wendelin, Nicola Gökbuget, Albrecht Reichle, Reingard Stuhlmann, Hubert Serve, H. Diedrich, Joachim Beck and Matthias Stelljes. Their work appears in journals such as Blood, Leukemia, Haematologica, The Lancet and DMW - Deutsche Medizinische Wochenschrift.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.